It certainly seems like we have a much more polished and useable platform now. Hopefully the likes of companies discussed to date are struggling with the " best we could find at the time" cpp's which are fundimental to their success. Hopefully we can readily show them we are however many times more effective we currently are than TAT, and if they ask for scientifically validated proof of cell entry and endosomal escape we just roll out CRE. Seems all our ducks are lined up, just need someone now willing to give us a go.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
0.040(3.33%) |
Mkt cap ! $723.2M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.24 | $1.19 | $1.500M | 1.241M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 204320 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 4333 | 2 |
View Market Depth
| Last trade - 16.11pm 24/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |